Hepatitis C virus eradication with direct antiviral agents and liver cancer recurrence: Is the best the enemy of the good?
Liver Int
.
2017 Aug;37(8):1110-1112.
doi: 10.1111/liv.13479.
Authors
Massimo Colombo
1
,
Savino Bruno
2
3
,
Ana Lleo
2
3
Affiliations
1
Center for Translational Research in Hepatology, Rozzano, Italy.
2
Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.
3
Hepatology, Department of Internal Medicine, Humanitas Clinical and Research Center, Rozzano, Italy.
PMID:
28710819
DOI:
10.1111/liv.13479
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antiviral Agents*
Hepacivirus*
Hepatitis C
Humans
Liver Neoplasms
Liver Transplantation
Neoplasm Recurrence, Local
Recurrence
Substances
Antiviral Agents